OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea flag South Korea · Delayed Price · Currency is KRW
184,600
-700 (-0.38%)
Apr 29, 2026, 3:30 PM KST

OliX Pharmaceuticals Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Cash & Equivalents
6,3593,88311,9834,93034,337
Upgrade
Short-Term Investments
91,900-10,00053,00015,000
Upgrade
Trading Asset Securities
34,2558,5313,9423,941420.68
Upgrade
Cash & Short-Term Investments
132,51312,41425,92561,87249,757
Upgrade
Cash Growth
967.42%-52.11%-58.10%24.35%-26.95%
Upgrade
Accounts Receivable
5,12795.113,55853.23-
Upgrade
Other Receivables
1,115907.841,419996.88272.13
Upgrade
Receivables
6,2421,0034,9771,050491.49
Upgrade
Inventory
396.71554.26468.41657.17374.13
Upgrade
Prepaid Expenses
1,5661,370244.91,3671,480
Upgrade
Other Current Assets
134.21192.88526.8699136.92
Upgrade
Total Current Assets
140,85115,53432,14265,04652,240
Upgrade
Property, Plant & Equipment
50,49951,38543,91037,23231,525
Upgrade
Long-Term Investments
1,3521,98623,48126,8090.5
Upgrade
Other Intangible Assets
1,9441,7051,9812,1072,134
Upgrade
Other Long-Term Assets
719.66639.621,3121,458772.05
Upgrade
Total Assets
195,36671,249102,825132,65186,672
Upgrade
Accrued Expenses
738.78488.52465.36358.62297.85
Upgrade
Short-Term Debt
64413,441---
Upgrade
Current Portion of Long-Term Debt
3,5713,572-19,23016,405
Upgrade
Current Portion of Leases
318.3745.851,065939.87487.8
Upgrade
Current Income Taxes Payable
2.8153.77---
Upgrade
Other Current Liabilities
16,05111,7595,03319,01423,174
Upgrade
Total Current Liabilities
21,32630,0606,56339,54340,365
Upgrade
Long-Term Debt
17,85721,42835,36220,00020,326
Upgrade
Long-Term Leases
895.925.382,9303,82651.69
Upgrade
Pension & Post-Retirement Benefits
-414.47--225.41
Upgrade
Other Long-Term Liabilities
5,208867.987,6343,0806,296
Upgrade
Total Liabilities
45,28752,77752,48966,44967,265
Upgrade
Common Stock
10,0959,2308,0106,8526,852
Upgrade
Additional Paid-In Capital
323,423175,533157,177151,89592,908
Upgrade
Retained Earnings
-191,586-167,785-122,910-103,224-84,303
Upgrade
Comprehensive Income & Other
6,458871.877,1418,8853,064
Upgrade
Total Common Equity
148,39017,84949,41864,40718,521
Upgrade
Minority Interest
699.37623.76481.45295.16886.27
Upgrade
Shareholders' Equity
150,07918,47350,33666,20319,407
Upgrade
Total Liabilities & Equity
195,36671,249102,825132,65186,672
Upgrade
Total Debt
23,28739,19239,35743,99637,271
Upgrade
Net Cash (Debt)
109,227-26,778-13,43317,87612,487
Upgrade
Net Cash Growth
---43.16%-76.70%
Upgrade
Net Cash Per Share
5553.79-1589.86-930.931304.50912.36
Upgrade
Filing Date Shares Outstanding
20.1918.4616.0213.713.7
Upgrade
Total Common Shares Outstanding
20.1918.4616.0213.713.7
Upgrade
Working Capital
119,525-14,52625,57825,50211,874
Upgrade
Book Value Per Share
7349.70966.923084.794700.191351.59
Upgrade
Tangible Book Value
146,44516,14447,43762,30016,387
Upgrade
Tangible Book Value Per Share
7253.40874.552961.164546.391195.84
Upgrade
Land
25,32525,46025,74025,74025,740
Upgrade
Buildings
22,69023,0333,3543,3543,354
Upgrade
Machinery
7,6597,4256,4365,5184,427
Upgrade
Construction In Progress
169.57-8,9481,23971.73
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.